Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_assertion type Assertion NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_head.
- NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_assertion wasGeneratedBy ECO_0000203 NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_provenance.
- NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_assertion wasDerivedFrom befree-20150227 NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_provenance.
- NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_assertion SIO_000772 23110092 NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_provenance.
- NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_assertion evidence source_evidence_literature NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_provenance.
- NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766455.RA3iqjtA2FmNgr9xzWYVf7SKRkFjcBRThraxTF3-wcw18130_provenance.